Helicos Bio Sciences Corp is categorized under Medical Research in Cambridge, MA and active since 2003.
Helicos Bio Sciences Corp was established in 2003, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact Marc Levine, Senior Vice President at the company’s headquarters by writing to 1 Kendall Square, Cambridge, Massachusetts MA 02139 or by phoning (617) 264-1800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Helicos Bio Sciences Corp |
| Contact Person: | Marc Levine, Senior Vice President |
| Address: | 1 Kendall Square, Cambridge, Massachusetts 02139 |
| Phone Number: | (617) 264-1800 |
| Website Address: | helicosbio.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2003 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 3254120 |
| Share This Business: |
Helicos Bio Sciences Corp was started in 2003 to provide professional Medical Research under the SIC code 8733 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Marc Levine, Senior Vice President for inquiries that concern Helicos Bio Sciences Corp by calling the company number (617) 264-1800, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Helicos Bio Sciences Corp can be found at the coordinates 42.3631,-71.1033 as well as the street address 1 Kendall Square in Cambridge, Massachusetts 02139.
For its online presence, you may visit Helicos Bio Sciences Corp’s website at helicosbio.com and engage with its social media outlets through on Twitter and on Facebook.